Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
Unilever (LSE:ULVR) is exiting its Foods division through a merger with McCormick & Company, creating a combined global flavours-focused group.
The deal marks a shift in Unilever’s portfolio away from staple foods and towards beauty, personal care, and wellbeing.
Following the merger announcement, Unilever moved quickly to acquire US-based supplements player Grüns to grow its health and wellness presence.
Unilever is known for its broad mix of consumer brands across foods, home care, and personal care, and the McCormick deal would reshape that profile. The exit from Foods aligns the group more closely with beauty, personal care, and wellness categories that many global consumer companies are prioritising. For investors, LSE:ULVR starts to look less like a classic staples company and more like a focused brand owner in potentially higher margin, premium segments.
The Grüns acquisition gives Unilever a foothold in the US supplements space at a time when consumer interest in health, self care, and functional products remains strong. As these transactions progress, investors will be watching how Unilever executes on brand integration, capital allocation, and balance sheet flexibility, as it builds out a more concentrated beauty and wellbeing portfolio.
Stay updated on the most important news stories for Unilever by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Unilever.
LSE:ULVR Earnings & Revenue Growth as at Apr 2026
We’ve flagged 2 risks for Unilever. See which could impact your investment.
Price vs Analyst Target: At £43.13 versus a £52.59 analyst target, the price sits about 18% below consensus expectations.
Simply Wall St Valuation: Shares are described as trading 24.2% below an estimated fair value, which supports a value angle.
Recent Momentum: The 30 day return of roughly 10.8% decline shows recent sentiment has been weak.
There is only one way to know the right time to buy, sell or hold Unilever. Head to Simply Wall St’s company report for the latest analysis of Unilever’s Fair Value.
The shift out of Foods and into beauty, wellbeing, and supplements changes Unilever’s mix and may alter how you think about its role in a portfolio.
Watch how management handles integration of Grüns, progress on debt and cash flows, and whether the P/E of 19.0 stays in line with the new profile.
One flagged risk is Unilever’s high level of debt, which matters as it restructures and pursues further deals.
For the full picture including more risks and rewards, check out the complete Unilever analysis. Alternatively, you can check out the community page for Unilever to see how other investors believe this latest news will impact the company’s narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ULVR.L.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
